Andrew J Brown (Andrew Brown)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Nature reviews. Drug discovery

Pharmacology research & perspectives

Drug testing and analysis

GlaxoSmithKline Research and Development

University of Edinburgh (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline Research and Development

United Kingdom

Senior Scientific Investigator

Education History

University of Edinburgh

United Kingdom

PHD :: ICMB

Publications

Richard J Brennan, Stephen Jenkinson, Andrew J Brown, Annie Delaunois, Bérengère Dumotier, Malar Pannirselvam, Mohan Rao, Lyn Rosenbrier Ribeiro, Friedemann Schmidt, Alicia Sibony, Yoav Timsit, Vicencia Toledo Sales, Duncan Armstrong, Armando Lagrutta, Scott W Mittlestadt, Russell Naven, Ravikumar Peri, Sonia Roberts, James M Vergis, Jean-Pierre Valentin
The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature reviews. Drug discovery 23 (7) (2024)
Richard J Brennan, Stephen Jenkinson, Andrew J Brown, Annie Delaunois, Bérengère Dumotier, Malar Pannirselvam, Mohan Rao, Lyn Rosenbrier Ribeiro, Friedemann Schmidt, Alicia Sibony, Yoav Timsit, Vicencia Toledo Sales, Duncan Armstrong, Armando Lagrutta, Scott W Mittlestadt, Russell Naven, Ravikumar Peri, Sonia Roberts, James M Vergis, Jean-Pierre Valentin
The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature reviews. Drug discovery 23 (7) (2024)
Richard J Brennan, Stephen Jenkinson, Andrew J Brown, Annie Delaunois, Bérengère Dumotier, Malar Pannirselvam, Mohan Rao, Lyn Rosenbrier Ribeiro, Friedemann Schmidt, Alicia Sibony, Yoav Timsit, Vicencia Toledo Sales, Duncan Armstrong, Armando Lagrutta, Scott W Mittlestadt, Russell Naven, Ravikumar Peri, Sonia Roberts, James M Vergis, Jean-Pierre Valentin
The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature reviews. Drug discovery (2024)
Richard J Brennan, Stephen Jenkinson, Andrew J Brown, Annie Delaunois, Bérengère Dumotier, Malar Pannirselvam, Mohan Rao, Lyn Rosenbrier Ribeiro, Friedemann Schmidt, Alicia Sibony, Yoav Timsit, Vicencia Toledo Sales, Duncan Armstrong, Armando Lagrutta, Scott W Mittlestadt, Russell Naven, Ravikumar Peri, Sonia Roberts, James M Vergis, Jean-Pierre Valentin
The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature reviews. Drug discovery 23 (7) (2024)
Richard J Brennan, Stephen Jenkinson, Andrew J Brown, Annie Delaunois, Bérengère Dumotier, Malar Pannirselvam, Mohan Rao, Lyn Rosenbrier Ribeiro, Friedemann Schmidt, Alicia Sibony, Yoav Timsit, Vicencia Toledo Sales, Duncan Armstrong, Armando Lagrutta, Scott W Mittlestadt, Russell Naven, Ravikumar Peri, Sonia Roberts, James M Vergis, Jean-Pierre Valentin
The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature reviews. Drug discovery (2024)
Richard J Brennan, Stephen Jenkinson, Andrew J Brown, Annie Delaunois, Bérengère Dumotier, Malar Pannirselvam, Mohan Rao, Lyn Rosenbrier Ribeiro, Friedemann Schmidt, Alicia Sibony, Yoav Timsit, Vicencia Toledo Sales, Duncan Armstrong, Armando Lagrutta, Scott W Mittlestadt, Russell Naven, Ravikumar Peri, Sonia Roberts, James M Vergis, Jean-Pierre Valentin
Author Correction: The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature reviews. Drug discovery (2024)
Richard J Brennan, Stephen Jenkinson, Andrew J Brown, Annie Delaunois, Bérengère Dumotier, Malar Pannirselvam, Mohan Rao, Lyn Rosenbrier Ribeiro, Friedemann Schmidt, Alicia Sibony, Yoav Timsit, Vicencia Toledo Sales, Duncan Armstrong, Armando Lagrutta, Scott W Mittlestadt, Russell Naven, Ravikumar Peri, Sonia Roberts, James M Vergis, Jean-Pierre Valentin
The state of the art in secondary pharmacology and its impact on the safety of new medicines. Nature reviews. Drug discovery (2024)
Thomas J Hudzik, Metul Patel, Andrew J Brown
β2 -Adrenoceptor agonist activity of higenamine. Drug testing and analysis 13 (2) (2021)
Jak Grimes, Sapna Desai, Neil W Charter, James Lodge, Rita Moita Santos, Albert Isidro-Llobet, Andrew M Mason, Zining Wu, Lawrence A Wolfe, Lakshmi Anantharaman, Andrew Green, Angela M Bridges, Deidre A Dalmas Wilk, Andrew J Brown
MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo-allergic and anaphylactoid reactions. Pharmacology research & perspectives 7 (6) (2019)
James R Foster, Shohta Ueno, Mao Xiang Chen, Jenni Harvey, Simon J Dowell, Andrew J Irving, Andrew J Brown
N-Palmitoylglycine and other N-acylamides activate the lipid receptor G2A/GPR132. Pharmacology research & perspectives 7 (6) (2019)

Andrew J Brown.css-eqlu8i{font-size:small;padding-left:4px;} (Andrew Brown)

Publication Activity (10 Years)

Top Topics

Top Venues

Andrew J Brown (Andrew Brown)